Chemometric modelling of antimalarial activity of aryltriazolylhydroxamates

References

• World Malaria Report (2008) WHO, Geneva, Switzerland. Available at http://www.who.int/malaria/publications/atoz/9789241563697/en/index.html.
   Google Scholar
• Murray , M.C. and Perkins , M.E. 1996 . Chemotherapy of malaria . Annu. Rep. Med. Chem. , 31 : 141 – 150 .
   Web of Science ®Google Scholar
• Vroman , J.A. , Gaston , M.A. and Avery , M.A. 1999 . Current progress in the chemistry, medicinal chemistry and drug design of artemisinin based antimalarials . Curr. Pharm. Des. , 5 : 101 – 138 .
   PubMed Web of Science ®Google Scholar
• Gregson , A. and Plowe , C.V. 2005 . Mechanisms of resistance of malaria parasites to antifolates . Pharmacol. Rev. , 57 : 117 – 145 .
   PubMed Web of Science ®Google Scholar
• Duffy , P.E. and Sibley , C.H. 2005 . Are we losing artemisinin combination therapy already? . Lancet , 366 : 1908 – 1909 .
   PubMed Web of Science ®Google Scholar
• Ridley , R.G. 2002 . Medical need, scientific opportunity and the drive for antimalarial drugs . Nature , 41 : 5686 – 5693 . (London)
   Google Scholar
• Gonzalez , M.P. , Teran , C. , Saiz-Urra , L. and Teijeira , M. 2008 . Variable selection methods in QSAR: An overview . Curr. Top. Med. Chem. , 8 : 1606 – 1627 .
   PubMed Web of Science ®Google Scholar
• Adane , L. and Bharatam , P.V. 2009 . 3D-QSAR analysis of cycloguanil derivatives as inhibitors of A16V+S108T mutant Plasmodium falciparum dihydrofolate reductase enzyme . J. Mol. Graph. Model , 28 : 357 – 367 .
   PubMed Web of Science ®Google Scholar
• Cruz-Monteagudo , M. , Borges , F. , Gonzalez , M.P. and Cordeiro , M.N.D.S. 2007 . Computational modeling tools for the design of potent antimalarial bisbenzamidines: Overcoming the antimalarial potential of pentamidine . Bioorg. Med. Chem. , 15 : 5322 – 5339 .
   PubMed Web of Science ®Google Scholar
• Katritzky , A.R. , Kulshyn , O.V. , Stoyanova-Slavova , I. , Dobchev , D.A. , Kuanar , M. , Fara , D.C. and Karelson , M. 2006 . Antimalarial activity: A QSAR modeling using CODESSA PRO software . Bioorg. Med. Chem. , 14 : 2333 – 2357 .
   PubMed Web of Science ®Google Scholar
• Parenti , M.D. , Pacchioni , S. , Ferrari , A.M. and Rastelli , G. 2004 . 3D quantitative structure–activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach . J. Med. Chem. , 47 : 4258 – 4267 .
   PubMed Web of Science ®Google Scholar
• Patil , V. , Guerrant , W. , Chen , P.C. , Gryder , B. , Benicewicz , D.B. , Khan , S.I. , Tekwani , B.L. and Oyelere , A.K. 2010 . Antimalarial and antileishmanial activities of histone deacetylase inhibitors with triazole-linked cap group . Bioorg. Med. Chem. , 18 : 415 – 425 .
   PubMed Web of Science ®Google Scholar
• Makler , M.T. , Ries , J.M. , Williams , J.A. , Bancroft , J.E. , Piper , R.C. , Gibbins , B.L. and Hinriches , D.J. 1993 . Parasite lactate dehydrogenase as an assay for Plasmodium falciparum drug sensitivity . Am. J. Trop. Med. Hyg. , 48 : 739 – 741 .
   PubMed Web of Science ®Google Scholar
• Cerius2 Version 4.10, a product of Accelrys, Inc., San Diego, USA; software available at http://www.accelrys.com/cerius2.
   Google Scholar
• Eriksson , L. , Jaworska , J. , Worth , A.P. , Cronin , M.T.D. , Robert , M.M. and Gramatica , P. 2003 . Methods for reliability and uncertainty assessment and for applicability evaluations of classification and regression-based QSARs . Environ. Health Perspect. , 111 : 1361 – 1375 .
   PubMed Web of Science ®Google Scholar
• Guha , R. and Jurs , P.C. 2005 . Determining the validity of a QSAR model – A classification approach . J. Chem. Inf. Model , 45 : 65 – 73 .
   PubMed Web of Science ®Google Scholar
• Leonard , J.T. and Roy , K . 2006 . On selection of training and test sets for the development of predictive QSAR models . QSAR Comb. Sci. , 25 : 235 – 251 .
   Google Scholar
• Roy , K. 2007 . On some aspects of validation of predictive QSAR models . Expert Opin. Drug Discov. , 2 : 1567 – 1577 .
   PubMed Web of Science ®Google Scholar
• Everitt , B.S. , Landau , S. and Leese , M. 2001 . Cluster Analysis , London : Edward Arnold .
   Google Scholar
• Dougherty , E.R. , Barrera , J. , Brun , M. , Kim , S. , Cesar , R.M. , Chen , Y. , Bittner , M. and Trent , J.M. 2002 . Inference from clustering with application to gene-expression microarrays . J. Comput. Biol. , 9 : 105 – 126 .
   PubMed Web of Science ®Google Scholar
• Johnson , R.A. and Wichern , D.W. 2005 . Applied Multivariate Statistical Analysis , 668 – 730 . Delhi : Pearsons .
   Google Scholar
• SPSS is statistical software of SPSS Inc., USA.
   Google Scholar
• Rogers , D. and Hopfinger , A.J. 1994 . Application of genetic function approximation to quantitative structure–activity relationships and quantitative structure–property relationships . J. Chem. Inf. Comput. Sci. , 34 : 854 – 866 .
   Google Scholar
• Wold , H. 1966 . Research Papers in Statistics , New York : Wiley .
   Google Scholar
• Jores-Kong , H. and Wold , H. 1982 . Systems under Indirect Observation: Causality, Structure, Prediction , Amsterdam : North-Holland .
   Google Scholar
• Wold , S. and Eriksson , L. 1995 . “ Validation tools ” . In Chemometric Methods in Molecular Design , Edited by: van de Waterbeemd , H. 312 – 317 . Weinheim : VCH .
   Google Scholar
• Fan , Y. , Shi , L.M. , Kohn , K.W. , Pommier , Y. and Weinstein , J.N. 2001 . Quantitative structure–antitumor activity relationships of camptothecin analogues: Cluster analysis and genetic algorithm-based studies . J. Med. Chem. , 44 : 3254 – 3263 .
   PubMed Web of Science ®Google Scholar
• Roy , P.P. and Roy , K. 2008 . On some aspects of variable selection for partial least squares regression models . QSAR Comb. Sci. , 27 : 302 – 313 .
   Google Scholar
• Kulkarni , S.S. and Kulkarni , V.M. 1999 . 3D quantitative structure–activity relationship of interleukin 1-beta converting enzyme inhibitors: A comparative molecular field analysis study . J. Med. Chem. , 42 : 373 – 380 .
   PubMed Web of Science ®Google Scholar
• Roy , P.P. , Leonard , J.T. and Roy , K. 2008 . Exploring the impact of the size of training sets for the development of predictive QSAR models . Chemom. Intel. Lab. Sys. , 90 : 31 – 42 .
   Web of Science ®Google Scholar
• Kubinyi , H. , Hamprecht , F.A. and Mietzner , T. 1998 . 3D quantitative similarity–activity relationships (3D QSiAR) from SEAL similarity matrices . J. Med. Chem. , 41 : 2553 – 2564 .
   PubMed Web of Science ®Google Scholar
• Marshall , G.R. 1994 . “ In 3D QSAR in drug design – Theory, methods and applications ” . Edited by: Kubinyi , H. 117 – 133 . Leiden : ESCOM .
   Google Scholar
• Roy , P.P. , Paul , S. , Mitra , I. and Roy , K. 2009 . On two novel parameters for validation of predictive QSAR models . Molecules , 14 : 1660 – 1701 .
   PubMed Web of Science ®Google Scholar
• Mitra , I. , Roy , P.P. , Kar , S. , Ojha , P.K. and Roy , K. 2010 . On further application of r2 m as a metric for validation of QSAR models . J. Chemom. , 24 : 22 – 33 .
   Web of Science ®Google Scholar
• Roy , K. and Paul , S. 2009 . Exploring 2D and 3D QSARs of 2,4-diphenyl-1,3-oxazolines for ovicidal activity against tetranychus urticae . QSAR Comb. Sci. , 28 : 406 – 425 .
   Google Scholar
• Roy , K. and Paul , S. 2010 . Docking and 3D QSAR studies of protoporphyrinogen oxidase inhibitor 3H-pyrazolo [3,4-d] [1,2,3] triazin-4-one derivatives . J. Mol. Model , 16 : 137 – 153 .
   PubMedGoogle Scholar
• MINITAB is a statistical software of Minitab Inc., USA.
   Google Scholar
• STATISTICA is a statistical software of STATSOFT Inc., USA.
   Google Scholar
• Kier , L.B. 1989 . An index of molecular flexibility from kappa shape attributes . Quant. Struct. Act. Relat. , 8 : 221 – 224 .
   Google Scholar